- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition ; volume:7 ; number:1 ; day:15 ; month:12 ; year:2023 ; pages:1-14 ; date:12.2023
npj precision oncology ; 7, Heft 1 (15.12.2023), 1-14, 12.2023
- Urheber
-
Lai, Xianning
Lui, Sarah Kit Leng
Lam, Hiu Yan
Adachi, Yuta
Sim, Wen Jing
Vasilevski, Natali
Armstrong, Nicola J.
Bridgeman, Stephanie Claire
Main, Nathan Michael
Tan, Tuan Zea
Tirnitz-Parker, Janina E. E.
Thiery, Jean Paul
Ebi, Hiromichi
Kumar, Alan Prem
Eichhorn, Pieter Johan Adam
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-023-00486-6
- URN
-
urn:nbn:de:101:1-2024030107494533806028
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lai, Xianning
- Lui, Sarah Kit Leng
- Lam, Hiu Yan
- Adachi, Yuta
- Sim, Wen Jing
- Vasilevski, Natali
- Armstrong, Nicola J.
- Bridgeman, Stephanie Claire
- Main, Nathan Michael
- Tan, Tuan Zea
- Tirnitz-Parker, Janina E. E.
- Thiery, Jean Paul
- Ebi, Hiromichi
- Kumar, Alan Prem
- Eichhorn, Pieter Johan Adam
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer
TGF-β signalling in nervous system development
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
Toward personalized TGFβ inhibition for pancreatic cancer
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth
KRAS Q61H Mutation Confers Cancer Cells with Acquired Resistance to SHP2 Inhibition
MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer
TGF-β signalling in nervous system development
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
Toward personalized TGFβ inhibition for pancreatic cancer
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth
KRAS Q61H Mutation Confers Cancer Cells with Acquired Resistance to SHP2 Inhibition
MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer
TGF-β signalling in nervous system development
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
Toward personalized TGFβ inhibition for pancreatic cancer
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth
KRAS Q61H Mutation Confers Cancer Cells with Acquired Resistance to SHP2 Inhibition